CLASS II ONGOING Device recall · Reported 9 Apr 2025 · FDA Enforcement Report

Terumo CDI OneView Monitoring System Hematocrit / Oxygen recalled

Terumo Cardiovascular Systems is recalling Terumo CDI OneView Monitoring System Hematocrit / Oxygen Saturation Probe, distributed in Florida, Illinois, Michigan, Nevada, New York, Texas. The recall was initiated on 3 Mar 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI/DI 00886799001882, Serial Number range: H0050095-H0050110, H0050112-H0050116, H0050118-H0050124, H0050126, H0050131-H0050134, H0050136, H0050140-H0050142
Quantity recalled37 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1492-2025
FDA event ID
96331
Recalling firm
Terumo Cardiovascular Systems, Ann Arbor, MI
Classification
Class II
Status
Ongoing
Recall initiated
3 Mar 2025
FDA classified
31 Mar 2025
Reported
9 Apr 2025
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction
Device type
Patient Monitors

Timeline

3 Mar 2025Recall initiated by company
31 Mar 2025Classified by FDA+28 days
9 Apr 2025Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

During some clinical cases, it has been observed that the SO2 value may periodically appear as dashes on the Touchscreen Display indicating unavailable data. In these cases, a yellow low-limit alarm will also be triggered to the user, due to the dashed-out value.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Terumo CDI OneView Monitoring System Hematocrit / Oxygen Saturation Probe, Catalog Number REF CD1754

Where it was distributed

US: IL, TX, NY, MI, FL, NV, and Australia, New Zealand

FloridaIllinoisMichiganNevadaNew YorkTexas

Questions about this recall

Why was it recalled?

During some clinical cases, it has been observed that the SO2 value may periodically appear as dashes on the Touchscreen Display indicating unavailable data. In these cases, a yellow low-limit alarm will also be triggered to the user, due to the dashed-out value.

Which lots are affected?

UDI/DI 00886799001882, Serial Number range: H0050095-H0050110, H0050112-H0050116, H0050118-H0050124, H0050126, H0050131-H0050134, H0050136, H0050140-H0050142

Where was it sold?

US: IL, TX, NY, MI, FL, NV, and Australia, New Zealand

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Terumo Cardiovascular Systems

All 222

Other Patient Monitors recalls

All 1,014